Abbott Laboratories (NYSE:ABT) ranks among the top picks for a retirement portfolio. UBS maintained Abbott Laboratories (NYSE:ABT) as a top choice in the Medical Supplies and Devices industry on September 23, reaffirming its Buy rating on the company’ shares with a price target of $154. The firm expressed strong confidence in the company’s future trajectory, with particular focus on Abbott’s MedTech division, which it believes can maintain growth rates of 10% or more. UBS expects Abbott Laboratories (NYS ...